TearClear
Boston
About TearClear
TearClear is a pharmaceutical company that specializes in providing a class platform of drugs that enables medication delivery to ultimately enhance patient safety and compliance by capturing preservatives before they reach the ocular surface. Founded in 2015, TearClear is headquartered in California, United States.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $52.0M
- Last round: Series Unknown (Jul 2023)
- Website: tearclear.com
- Phone: 617-454-7251
Industries & Categories
Chemical Engineering, Medical Device, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/tearclear-66051 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.